NURS 6050 Week 4 : Legislation Comparison Grid and Testimony Assignment
NURS 6050 Week 4 : Legislation Comparison Grid and Testimony Assignment
NURS 6050 Week 4 : Legislation Comparison Grid and Testimony Assignment
1
Legislation Grid Template
Use this document to complete Part 1 of the Module 2 Assessment Legislation Grid and Testimony/Advocacy Statement
Health-related Bill Name | Medicare Negotiation and Competitive Licensing Act of 2021 |
Bill Number | H.R. 4811 |
Description | The Medicare Negotiation and Competitive Licensing Act of 2021 was primarily intended to cut the cost of prescription medications for Medicare enrollees. The bill sought to accomplish this goal by empowering the Secretary of Health and Human Services to negotiate directly with drug makers to reduce the pricing of certain high-cost prescription medications covered by Medicare Part D (GovInfo, 2023). Furthermore, the bill enabled the use of competitive licensing to reduce medicine prices. If a medication manufacturer refuses to negotiate a fair price for a drug, the government may license the drug to other firms to create and sell at a cheaper cost, enhancing market competition and potentially driving down costs. |
Federal or State? | Federal |
Legislative Intent | The legislative intent of the Medicare Negotiation and Competitive Licensing Act of 2021 was to empower the Secretary of Health and Human Services to negotiate directly with drug manufacturers to lower the cost of prescription drugs for Medicare beneficiaries. The bill aims to increase competition in the prescription drug market and allow for the importation of safe and affordable drugs from other countries. |
Proponents/ Opponents | Proponents: Peter Welch (D-VT), Francis Rooney (R-FL), Alexandria Ocasio-Cortez (D-NY), Ilhan Omar (D-MN), and Pramila Jayapal (D-WA). |
Opponents: pharmaceutical industry | |
Target Population | 65 years adults and older |
Status of the bill (Is it in hearings or committees?) | Hearing |
General Notes/Comments | The Medicare Negotiation and Competitive Licensing Act of 2021 has the potential to cut the cost of prescription pharmaceuticals for Medicare beneficiaries, ensuring that people have access to the prescriptions they require to treat their health problems. This bill can assist in addressing growing healthcare costs and ensure fair access to drugs by directly negotiating with drug producers and through competitive licensing. It is important to acknowledge the role of socioeconomic factors in healthcare access and endeavor to eliminate these structural obstacles to care. This can help guarantee that all Medicare beneficiaries have access to the pharmaceuticals they need to live healthy, full lives by campaigning for the adoption of the Medicare Negotiation and Competitive Licensing Act of 2021 |
ORDER A PLAGIARISM-FREE PAPER HERE
Instructions:
Part One:
Based on a Health Related Bill Proposed NOT ENACTED. Complete the Legislation Grid (SEE ATTACHED)). Be sure to address the following:
1) Determine the legislative intent of the bill you have reviewed.
2) Identify the proponents/opponents of the bill.
3) Identify the target population addressed by the bill
4) Where in the process is the bill currently? Is it in hearings or committees?
Part Two:
Based on the health-related bill you have selected, develop a 1-page Legislation Testimony/Advocacy Statement that addresses the following:
1) Advocate a position for the bill you selected and write testimony in support of your position.
2) Explain how the social determinants of income, age, education, or gender affect this legislation.
3) Describe how you would address the opponent to your position. Be Specific and Provide Examples.
4) Have at least 2 outside resources/sources and 2-3 course-specific resources/sources are used.